Repaglinide - ≥99%, high purity , Sulfonylurea receptor 1, Kir6.2 blocker, CAS No.135062-02-1, Sulfonylurea receptor 1, Kir6.2 blocker

Item Number

R129561

• Synonyms: 111GE012 | CS-0979 | HMS2094C07 | NC00263 | SMP-508 | REPAGLINIDE (MART.) | 2-ethoxy-4-({[(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]carbamoyl}methyl)benzoic acid | HMS2051N08 | Repaglinida (INN-Spanish) | REPAGLINIDE (USP MONOGRAPH) | (S)-2-ethoxy-4
• Specifications & Purity: Moligand™, ≥99%
• Biochemical and Physiological Mechanisms: Repaglinide is a KIR6 (KATP) channel blocker that binds with high affinity for SUR1 when co-expressed with KIR6.2(Kd = 0.42 nM).Repaglinide is a potent short-acting insulin secretagogue that acts by closing ATP-sensitive potassium (KATP) channels in the p
• Storage Temp: Store at 2-8°C
• Shipped In: Wet ice
• Grade: Moligand™
• Action Type: BLOCKER, INHIBITOR
• Mechanism of action: Sulfonylurea receptor 1, Kir6.2 blocker
• Note: Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Product Description

Repaglinide is for the treatment of type II diabetes.
A KIR6 (KATP) channel blocker